132 | ruxolitinibIBA
02/2024
-
01/2009 |
56 | Janus Kinase InhibitorsIBA
02/2024
-
01/2009 |
42 | Imatinib Mesylate (Gleevec)FDA Link
01/2020
-
05/2002 |
41 | Janus KinasesIBA
11/2023
-
02/2008 |
25 | N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
02/2024
-
01/2017 |
24 | Janus Kinase 2IBA
05/2021
-
11/2005 |
22 | Tyrosine Kinase InhibitorsIBA
11/2021
-
09/2003 |
20 | CytokinesIBA
01/2024
-
01/2009 |
20 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021
-
05/2002 |
19 | InterferonsIBA
01/2024
-
06/2003 |
19 | Hydroxyurea (Hydrea)FDA LinkGeneric
07/2023
-
06/2006 |
18 | Phosphotransferases (Kinase)IBA
01/2022
-
03/2006 |
17 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
04/2024
-
01/2015 |
16 | Janus Kinase 1IBA
11/2023
-
01/2013 |
16 | Proteins (Proteins, Gene)FDA Link
11/2022
-
03/2002 |
15 | Hemoglobins (Hemoglobin)IBA
11/2023
-
05/2005 |
13 | fedratinibIBA
04/2023
-
01/2019 |
13 | Telomerase (Telomerase Reverse Transcriptase)IBA
12/2022
-
03/2003 |
13 | Interferon-alpha (Interferon Alfa)IBA
10/2016
-
01/2003 |
10 | Lenalidomide (CC 5013)FDA Link
01/2018
-
08/2006 |
9 | Reticulin (Reticular Fiber)IBA
01/2022
-
10/2009 |
9 | Arsenic Trioxide (Trisenox)FDA Link
01/2017
-
05/2003 |
8 | DecitabineFDA Link
01/2021
-
06/2005 |
8 | Dasatinib (BMS 354825)FDA Link
11/2020
-
06/2008 |
7 | IronIBA
01/2023
-
07/2006 |
7 | Alemtuzumab (Campath)FDA Link
01/2022
-
05/2003 |
7 | ArsenicIBA
04/2016
-
05/2003 |
7 | Prednisone (Sone)FDA LinkGeneric
01/2016
-
09/2009 |
6 | Danazol (Azol)FDA LinkGeneric
11/2023
-
12/2016 |
6 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2021
-
05/2002 |
6 | Clofarabine (Clolar)FDA Link
01/2021
-
10/2003 |
6 | Gemtuzumab (Mylotarg)FDA Link
01/2017
-
03/2003 |
6 | Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2017
-
05/2003 |
6 | Rituximab (Mabthera)FDA Link
11/2015
-
04/2003 |
5 | HepcidinsIBA
02/2024
-
01/2020 |
5 | Biomarkers (Surrogate Marker)IBA
02/2024
-
06/2022 |
5 | activin AIBA
11/2023
-
01/2023 |
5 | navitoclaxIBA
12/2022
-
01/2022 |
5 | imetelstatIBA
12/2022
-
01/2017 |
5 | Histone Deacetylase InhibitorsIBA
10/2022
-
11/2006 |
5 | CladribineFDA LinkGeneric
01/2021
-
08/2005 |
5 | fludarabineIBA
01/2020
-
03/2003 |
5 | nilotinibFDA Link
01/2020
-
07/2005 |
5 | Monoclonal AntibodiesIBA
01/2019
-
09/2004 |
5 | Thalidomide (Thalomid)FDA Link
01/2018
-
05/2006 |
5 | pomalidomideIBA
10/2017
-
09/2009 |
5 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003
-
03/2002 |
4 | Syntex adjuvant formulationIBA
02/2024
-
08/2016 |
4 | Activin Receptors (Activin Receptor)IBA
10/2023
-
12/2016 |
4 | LigandsIBA
12/2022
-
12/2016 |
4 | Messenger RNA (mRNA)IBA
01/2022
-
05/2002 |
4 | avapritinibIBA
12/2021
-
01/2018 |
4 | ErythropoietinFDA Link
01/2021
-
06/2008 |